Unknown

Dataset Information

0

Atypical mechanism of NF-?B activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis.


ABSTRACT: The NF-?B transcription factor has a central role in diverse processes, including inflammation, proliferation and cell survival, and its activity is dysregulated in diseases such as autoimmunity and cancer. We recently identified the TRE17/ubiquitin-specific protease 6 (USP6) oncogene as the first de-ubiquitinating enzyme to activate NF-?B. TRE17/USP6 is translocated and overexpressed in aneurysmal bone cyst (ABC), a pediatric tumor characterized by extensive bone degradation and inflammatory recruitment. In the current study, we explore the mechanism by which TRE17 induces activation of NF-?B, and find that it activates the classical NF-?B pathway through an atypical mechanism that does not involve I?B degradation. TRE17 co-precipitates with I?B kinase (IKK), and IKK activity is augmented in stable cell lines overexpressing TRE17, in a USP-dependent manner. Optimal activation of NF-?B by TRE17 requires both catalytic subunits of IKK, distinguishing its mechanism from the classical and non-canonical pathways, which require either IKK? or IKK?, respectively. TRE17 stimulates phosphorylation of p65 at serine 536, a modification that has been associated with enhanced transcriptional activity and nuclear retention. Induction of S536 phosphorylation by TRE17 requires both IKK? and IKK?, as well as the IKK?/NEMO regulatory subunit of IKK. We further demonstrate that TRE17(long) is highly tumorigenic when overexpressed in NIH3T3 fibroblasts, and that inhibition of NF-?B significantly attenuates tumor formation. In summary, these studies uncover an unexpected signaling mechanism for activation of classical NF-?B by TRE17. They further reveal a critical role for NF-?B in TRE17-mediated tumorigenesis, and suggest that NF-?B inhibitors may function as effective therapeutic agents in the treatment of ABC.

SUBMITTER: Pringle LM 

PROVIDER: S-EPMC3297677 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Atypical mechanism of NF-κB activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis.

Pringle L M LM   Young R R   Quick L L   Riquelme D N DN   Oliveira A M AM   May M J MJ   Chou M M MM  

Oncogene 20111114 30


The NF-κB transcription factor has a central role in diverse processes, including inflammation, proliferation and cell survival, and its activity is dysregulated in diseases such as autoimmunity and cancer. We recently identified the TRE17/ubiquitin-specific protease 6 (USP6) oncogene as the first de-ubiquitinating enzyme to activate NF-κB. TRE17/USP6 is translocated and overexpressed in aneurysmal bone cyst (ABC), a pediatric tumor characterized by extensive bone degradation and inflammatory re  ...[more]

Similar Datasets

| S-EPMC5026615 | biostudies-literature
| S-EPMC2978639 | biostudies-literature
| S-EPMC2892027 | biostudies-literature
| S-EPMC8197902 | biostudies-literature
| S-EPMC5748463 | biostudies-literature
| S-EPMC4889410 | biostudies-literature
| S-EPMC151371 | biostudies-literature
| S-EPMC4215716 | biostudies-other
| S-EPMC2862109 | biostudies-literature
| S-EPMC3545798 | biostudies-other